 | Up a level |
Mamlins, Eduards; Scharbert, Lara; Cardinale, Jens; Krotov, Maria; Winter, Erik; Rathke, Hendrik; Strodel, Birgit; Ankrah, Alfred O; Sathekge, Mike; Haberkorn, Uwe; Kratochwil, Clemens; Giesel, Frederik L (2024). The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular imaging and biology, 26(1), pp. 81-89. Springer-Verlag 10.1007/s11307-023-01881-y
Afshar-Oromieh, Ali; Eiber, Matthias; Fendler, Wolfgang; Schmidt, Matthias; Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Umutlu, Lale; Hadaschik, Boris; Hakenberg, Oliver W; Fornara, Paolo; Kurth, Jens; Neels, O; Wester, Hans-Jürgen; Schwaiger, Markus; Kopka, Klaus; Haberkorn, Uwe; Herrmann, Ken; Krause, Bernd J (2023). [Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT]. Nuklearmedizin, 62(1), pp. 5-19. Thieme 10.1055/a-1984-8167
Glatting, Frederik M; Hoppner, Jorge; Liew, Dawn P; van Genabith, Antonia; Spektor, Anna-Maria; Steinbach, Levin; Hubert, Alexander; Kratochwil, Clemens; Giesel, Frederik L; Dendl, Katharina; Rathke, Hendrik; Kauczor, Hans-Ulrich; Huber, Peter E; Haberkorn, Uwe; Röhrich, Manuel (2022). Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions. Journal of nuclear medicine, 63(12), pp. 1844-1851. Society of Nuclear Medicine 10.2967/jnumed.122.264069
Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Calais, Jeremie; Barbato, Francesco; Weber, Manuel; Afshar-Oromieh, Ali; Spohn, Fabian; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang Peter (2020). Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection using repeat PSMA-PET. The journal of nuclear medicine, 61(7), pp. 1037-1042. Society of Nuclear Medicine and Molecular Imaging 10.2967/jnumed.119.235374
Petersen, Lars J.; Nielsen, Julie B.; Langkilde, Niels C.; Petersen, Astrid; Afshar Oromieh, Ali; De Souza, Nandita M.; De Paepe, Katja; Fisker, Rune V.; Arp, Dennis T.; Carl, Jesper; Haberkorn, Uwe; Zacho, Helle D. (2020). 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study. World journal of urology, 38(4), pp. 939-948. Springer-Verlag 10.1007/s00345-019-02846-z
Haupt, Fabian; Dijkstra, Lotte; Alberts, Ian; Sachpekidis, Christos; Fech, Viktor; Boxler, Silvan; Gross, Tobias; Holland-Letz, Tim; Zacho, Helle D; Haberkorn, Uwe; Rahbar, Kambiz; Rominger, Axel; Afshar-Oromieh, Ali (2020). 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol. European journal of nuclear medicine and molecular imaging, 47(3), pp. 624-631. Springer-Verlag 10.1007/s00259-019-04548-5
Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Eiber, Matthias; Afshar-Oromieh, Ali; Spohn, Fabian; Barbato, Francesco; Weber, Manuel; Ilhan, Harun; Cervati, Veronica; Wetter, Axel; Hadaschik, Boris; Briganti, Alberto; Walz, Jochen; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken; Fendler, Wolfgang Peter (2019). 68 Ga-PSMA-11 PET Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study. Journal of urology, 202(6), pp. 1174-1181. Elsevier 10.1097/JU.0000000000000417
Debus, Charlotte; Afshar Oromieh, Ali; Floca, Ralf; Ingrisch, Michael; Knoll, Maximilian; Debus, Jürgen; Haberkorn, Uwe; Abdollahi, Amir (2018). Feasibility and robustness of dynamic 18F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation. Scientific Reports, 8(1), p. 14760. Nature Publishing Group 10.1038/s41598-018-33034-5
Afshar Oromieh, Ali; Debus, Nils; Uhrig, Monika; Hope, Thomas A.; Evans, Michael J.; Holland-Letz, Tim; Giesel, Frederik L.; Kopka, Klaus; Hadaschik, Boris; Kratochwil, Clemens; Haberkorn, Uwe (2018). Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. European journal of nuclear medicine and molecular imaging, 45(12), pp. 2045-2054. Springer-Verlag 10.1007/s00259-018-4079-z
Afshar Oromieh, Ali; Sattler, Lars Peter; Steiger, Katja; Holland-Letz, Tim; da Cunha, Marcelo Livorsi; Mier, Walter; Neels, Oliver; Kopka, Klaus; Weichert, Wilko; Haberkorn, Uwe (2018). Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT. European journal of nuclear medicine and molecular imaging, 45(7), pp. 1179-1187. Springer 10.1007/s00259-018-3965-8
Zacho, Helle D.; Nielsen, Julie B.; Afshar Oromieh, Ali; Haberkorn, Uwe; deSouza, Nandita; De Paepe, Katja; Dettmann, Katja; Langkilde, Niels C.; Haarmark, Christian; Fisker, Rune V.; Arp, Dennis T.; Carl, Jesper; Jensen, Jørgen B.; Petersen, Lars J. (2018). Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer. European journal of nuclear medicine and molecular imaging, 45(11), pp. 1884-1897. Springer-Verlag 10.1007/s00259-018-4058-4
Sachpekidis, Christos; Kopka, Klaus; Eder, Matthias; Hadaschik, Boris A; Freitag, Martin T; Pan, Leyun; Haberkorn, Uwe; Dimitrakopoulou-Strauss, Antonia (2016). 68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer. Clinical nuclear medicine, 41(11), e473-e479. Lippincott Williams & Wilkins 10.1097/RLU.0000000000001349
Kratochwil, Clemens; López-Benítez, Ruben; Mier, Walter; Haufe, Sabine; Isermann, Berend; Kauczor, Hans-Ulrich; Choyke, Peter L; Haberkorn, Uwe; Giesel, Frederik L (2011). Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases. Endocrine-related cancer, 18(5), pp. 595-602. Bristol: BioScientifica Ltd. 10.1530/ERC-11-0144
